Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents

被引:29
|
作者
Francis, Stuart [1 ]
Croft, Daniel [1 ]
Schtittelkopf, Alexander W. [1 ]
Parry, Charles [1 ]
Pughese, Angelo [1 ]
Cameron, Ken [1 ]
Claydon, Sophie [1 ]
Drysdale, Martin [1 ,4 ]
Gardner, Claire [1 ]
Gohlke, Andrea [1 ]
Goodwin, Gillian [1 ]
Gray, Christopher H. [1 ]
Konczal, Jennifer [1 ]
McDonald, Laura [1 ]
Mezna, Mokdad [1 ]
Pannifer, Andrew [1 ,5 ]
Paul, Nikki R. [2 ]
Machesky, Laura [2 ,3 ]
McKinnon, Heather [1 ]
Bower, Justin [1 ]
机构
[1] CRUK Beatson Inst, Drug Discovery Unit, Glasgow G61 1BD, Lanark, Scotland
[2] CRUK Beatson Inst, Cell Migrat Lab, Glasgow G61 1BD, Lanark, Scotland
[3] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland
[4] Broad Inst, Cambridge, MA 02142 USA
[5] Med Discovery Catapult, Alderly Pk, Alderley Edge SK10 4TG, England
关键词
Virtual screening; Fragments; Drug discovery; Medicinal chemistry; Cancer; LIGAND; CANCER;
D O I
10.1016/j.bmcl.2019.01.035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies.
引用
收藏
页码:1023 / 1029
页数:7
相关论文
共 50 条
  • [31] New [1,2,4]triazolo[4,3-c]quinazoline derivatives as vascular endothelial growth factor receptor-2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation
    Azab, Ahmed E.
    Alesawy, Mohamed S.
    Eldehna, Wagdy M.
    Elwan, Alaa
    Eissa, Ibrahim H.
    ARCHIV DER PHARMAZIE, 2022, 355 (10)
  • [32] Rational design, synthesis, and biological evaluation of novel C6-modified geldanamycin derivatives as potent Hsp90 inhibitors and anti-tumor agents
    Wang, Ruxuan
    Zhang, Rentao
    Yang, Haoran
    Xue, Nina
    Chen, Xiaoguang
    Yu, Xiaoming
    CHINESE CHEMICAL LETTERS, 2023, 34 (02)
  • [33] Design, Synthesis and Biological Evaluation of Novel Quinoline Derivatives as Potential Anti-Proliferative Agents Against PC-3 and KG-1 Cells
    Li, Kun
    Xu, Yuanbo
    Sun, Jun
    Zhang, Wei
    Ma, Peizhi
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (05) : 599 - 611
  • [34] Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors
    Liu, Siming
    Jiang, Ying
    Yan, Ruohong
    Li, Zhonghuang
    Wan, Shanhe
    Zhang, Tingting
    Wu, Xiaoyun
    Hou, Ju
    Zhu, Zhengguang
    Tian, Yuanxin
    Zhang, Jiajie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 358 - 375
  • [35] Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential
    Tilekar, Kalpana
    Upadhyay, Neha
    Hess, Jessica D.
    Macias, Lucasantiago Henze
    Mrowka, Piotr
    Aguilera, Renato J.
    Meyer-Almes, Franz-Josef
    Iancu, Cristina, V
    Choe, Jun-yong
    Ramaa, C. S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 202
  • [36] Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/I3 phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies
    Rostom, Sherif A. F.
    Badr, Mona H.
    Abd El Razik, Heba A.
    Ashour, Hayam M. A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 263 - 279
  • [37] Novel anti-cancer agents: design, synthesis, biological activity, molecular docking, and MD simulations of 2, 3, 4, 5-tetrahydro-1H-pyrido-[4,3-b]indole derivatives
    Feng, Yu
    Teng, Xingxing
    Gu, Jinhua
    Yu, Bangwei
    Luo, Yan
    Ye, Lianbao
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (02) : 133 - 142
  • [38] Design, Synthesis, Molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents
    Mekhlef, Yosra O.
    AboulMagd, Asmaa M.
    Gouda, Ahmed M.
    BIOORGANIC CHEMISTRY, 2023, 133
  • [39] Thieno[3,2-c]pyran-4-one based novel small molecules: Their synthesis, crystal structure analysis and in vitro evaluation as potential anticancer agents
    Nakhi, Ali
    Adepu, Raju
    Rambabu, D.
    Kishore, Ravada
    Vanaja, G. R.
    Kalle, Arunasree M.
    Pal, Manojit
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) : 4418 - 4427
  • [40] Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
    Eissa, Ibrahim H.
    El-Haggar, Radwan
    Dahab, Mohammed A.
    Ahmed, Marwa F.
    Mahdy, Hazem A.
    Alsantali, Reem, I
    Elwan, Alaa
    Masurier, Nicolas
    Fatahala, Samar S.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 1587 - 1599